HOME >> MEDICINE >> NEWS
Time to develop new antidotes for chemical attacks, urge researchers

New antidotes for organophosphates are needed to prepare for chemical attacks in the West and to tackle pesticide poisoning in developing countries, argue researchers in this week's BMJ.

Organophosphates are a group of organic compounds containing phosphorus, some of which are used as pesticides. Organophosphates have also been used in chemical weapons and nerve gas attacks, such as the sarin attack in Japan.

Organophosphate poisoning is a leading cause of premature death in the developing world, while Western nations are concerned about terrorist use of chemicals. Yet no new antidotes have been tested in clinical trials in the last 30 years. An international collaboration is needed to make a concerted effort to develop and test new treatments that would benefit both groups of patients, write the authors.

Atropine is currently the only clearly proved and moderately effective treatment for organophosphate poisoning. Information on potential treatments has been available for years, but neither the military nor the pharmaceutical industry has attempted to test them or develop new drugs.

The pharmaceutical industry has little incentive to develop new drugs for use primarily in developing countries, add the authors. However, on humanitarian grounds alone, research into organophosphate pesticide poisoning in developing countries should become an international priority.

Recent concerns by government about having the means to respond to victims of chemical warfare and terrorist attacks means that the time is ripe to break this drug development impasse, they conclude.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
18-Nov-2004


Page: 1

Related medicine news :

1. Late developers may run higher risk of infection than sexually mature younger teens
2. Hospital acquired infections present major problem for infants in developing countries
3. Targeting mutant B-Raf protein reduces melanoma development
4. Liverpool to lead 20M Department of Health initiative to develop medicines for children
5. Helping answer needs by developing specialists in autism
6. Common anesthetics appear safe for developing fetal brain
7. UCSD-Utah team develops mouse model to test therapies for macular degeneration
8. Hopkins convenes consensus conference to develop blueprint for nationwide matching program
9. Daily supplement may boost birthweight of babies in the developing world
10. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
11. OHSU scientists develop MRI approach to improve breast cancer detection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology:
Cached News: